CAH

In the past six months (April 2026 to October 2026), several events have impacted Cardinal Health's stock price. On October 1, 2026, the company announced a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032, which led to a +3.44% increase in the stock price. On August 11, 2026, the company reported strong Fourth Quarter and Fiscal Year 2026 results, exceeding earnings per share (EPS) estimates and showing double-digit profit growth across all five operating segments, resulting in a +1.13% stock gain, and the Board of Directors approved an increase in the quarterly dividend. On July 20, 2026, Cardinal Health expanded its home care business through two tuck-in acquisitions. In April 2026, the company released its 2026 Advanced Therapies Report and expanded its Actinium-225 production capabilities. Overall, Cardinal Health's stock price increased by 48.2% to 49.10% over the last 12 months (ending October 7, 2026), although it experienced a 5.37% decrease in the month leading up to October 6, 2026. The stock reached an all-time high of $258.30 on August 11, 2026.